|
About This Webinar 3.4 million people in the United States live
with active epilepsy. Psychiatric disorders, including depression, anxiety
and attention deficit disorders commonly occur in people with epilepsy and
often present as complex and challenging comorbidities to manage. Presenter Dr. Jay Salpekar, MD, FANPA Moderator Elaine T. Kiriakopoulos, MD, MSc Learning Objectives •Describe the prevalence of psychiatric comorbidities in epilepsy Disclosure Policy It is the policy of the American Epilepsy Society (AES) to ensure balance, independence, objectivity and scientific rigor. All individuals involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. Conflicts of interest will be resolved by AES prior to an educational activity being delivered to learners.Planning Committee, Faculty, Reviewers' Disclosures of Financial Relationships In accordance with the ACCME Standards for Integrity and Independence in Accredited Continuing Education, the AES requires that any person who is in a position to control content of a CME activity must disclose all relevant financial relationships that they have with an ineligible company. Unless otherwise indicated (*), none of the planners or faculty of this activity have any financial relationships to disclose. All relevant financial relationships with ineligible companies have been mitigated. The following individuals contributed to this activity’s content. The following individuals contributed to this activity’s content. Planning Committee* and Faculty Alexis Griffith, MPH American Epilepsy Society Shawna Strickland, PhD, CAE, RRT, FAARC American Epilepsy Society Elaine T. Kiriakopoulos, MD, MSc Geisel School of Medicine at Dartmouth College CME Reviewer Dr. Elaine Seto American Epilepsy Society Staff Planners Alexis Griffith, MPH Shawna Strickland, PhD, CAE, RRT, FAARC Kandice Kidd, MA Cristina Graham Resolution of Conflicts of Interest It is the policy of the American Epilepsy Society to ensure balance, independence, objectivity and scientific rigor. All persons involved in the selection, development and presentation of content are required to disclose any real or apparent conflicts of interest. In accordance with the ACCME Standards of Integrity and Independence in Accredited Continuing Education, the AES implemented the mechanisms of prospective peer review of this CME activity, to identify and resolve any conflicts. Additionally, the content of this activity is based on the best available evidence. Accreditation The American Epilepsy Society is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. For more information regarding contact hours, please call American Epilepsy Society 312.883.3800 or education@aesnet.org. Credit Designation The American Epilepsy Society designates this enduring activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. CME Certificate To receive credit for your participation in this activity, please complete the evaluation survey provided at the conclusion of the activity. Unapproved Use Disclosure The American Epilepsy Society requires CME authors to disclose to learners when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information. Information about pharmaceutical agents/devices that is outside of U.S. Food and Drug Administration approved labeling may be contained in this activity. Disclaimer This CME activity is for educational purposes only and does not constitute the opinion or endorsement of, or promotion by, the American Epilepsy Society. Reasonable efforts have been taken to present educational subject matter in a balanced, unbiased fashion, and in compliance with regulatory requirements. However, each activity participant must always use his or her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label, investigational and/or experimental uses.
|